| Name |
Level II (Policies) |
Level III (Clinical Practice) |
Level IV (Outcomes) |
Lau (7782) |
- Evidence-based guidelines for non-diabetic renal disease (National Kidney Foundation's Kidney Disease Outcomes Quality Initiative).
- Clinical trials checklist (Working Group on Recommendations for the Reporting of Clinical Trials in the Biomedical Literature).
- Clinical trial registries resulting from this work were contributed to key collaborative review groups in the areas of congestive heart failure and hypertension.
|
- Shift in treatment patterns toward single-dose treatment with aminoglycosides for serious infection.
|
|
Ray (7768) |
- Guidelines for the management of osteoarthritis of the hip and knee.
|
|
|
Berman (7816) |
- Guidelines for Otitis Media for Colorado Medicaid.
- Program to evaluate OM outcomes (AMA).
- Interactive training Web site, and workshop (American Academy of Pediatrics).
- HEDIS measures (NCQA).
|
|
|
Soumerai (7631) |
- Policies on appropriate use of beta-blockers (NCQA, AMA, major HMOs).
|
- Increased rates of prescription of beta-blockers.
|
- Reduction in mortality associated with heart attacks.
|
Moore (7809) |
- HIV/AIDS-related policies (FDA, HRSA's HIV AIDS Bureau, Infectious Disease Society of America, the HIV Care Association and several pharmaceutical companies).
|
- Findings on the value of combination therapy relative to monotherapy resulted in significant shift in treatment patterns.
- Demonstrated the value of long-term safety of adjunctive corticosteroids.
- Increased treatment of opportunistic diseases.
|
- Change in natural history of HIV/AIDS resulting from combination therapy.
|
Garrard (7772) |
- Plan and provider awareness of cost and treatment issues associated with depression among the elderly (HealthPartners HMO).
|
|
|
Strickland (7813) |
- Health plan provider education and guidelines related to Lyme disease diagnosis, testing and treatment.
|
- Decline in rate of use of expensive antibiotics and over-treatment of tick bites in HMO (Delmarva Health Plan, MD).
|
|
Gardner (8217) |
- Study confirmed value of co-payment structure for prescription drug in a state health insurance program (Oregon Public Employees Retirement System), and demonstrated to the program the value of linking claims and clinical information to enhance quality and cost-effectiveness.
|
|
|